HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Brittany ...

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced abstract acceptance with a ...

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Juhyun ...

Joe Turgeon, President and Chief Executive Officer, to retire and step down from Board of Directors “We welcome Tom as the new CEO of Spectrum and look forward to the continued benefits of his ...

It seems people like Spectrum Pharmaceuti-cals Inc.’s new personality. Spectrum, which made a name selling generic drugs, has reinvented itself as a branded drug maker and seen sales soar. The ...

Spectrum Pharmaceuticals’ neutropenia candidate Rolontis certainly hasn’t had the easiest trip through the FDA. On Friday, the company unveiled another setback. The FDA turned down Rolontis’ ...

Spectrum Pharmaceuticals has weathered changes and challenges in recent years, including a sale of its marketed drugs portfolio in 2019 and an FDA rejection for a key prospect last year. Now, it's ...

SAN FRANCISCO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No.

Irvine’s Spectrum Pharmaceuticals Inc. is looking to make a name for itself. The company has made moves to jump from generic versions of common drugs to brand-name treatments for cancer. For now, ...

(Allos) today announced that, on May 9, 2012, each had received from the Federal Trade Commission (FTC) a Request for Additional Information and Documentary Material (Second Request) under the ...